AGIO compared with CRNX: revenue, margins and what each company keeps, and the suppliers and customers both name

AGIOAgios Pharmaceuticals, Inc.

Mkt capRevenueRevenue

CRNXCrinetics Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

AGIOAgios Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AGIO

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.7%▼−6.46%×0.67

Q1 FY26±9.2%▲+13.10%×1.42

Feb 12 '26±9.8%▲+1.30%×0.13

Oct 30 '25±12.6%▲+2.91%×0.23

CRNX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±1.1%▲+0.12%×0.09

May 8 '26±9.5%▼−13.82%×1.45

= impliedAGIO realized, solidCRNX realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.4%

▼−6.04%

×0.48

Jan 6 '26±10.1%▼−4.63%×0.46

AGIOAgios Pharmaceuticals, Inc.

29.93· pre 29.90· delayed

Mkt cap$1.8BRevenue$45MQ2 FY26Revenue$54MFY25

CRNXCrinetics Pharmaceuticals, Inc.

84.97· pre 84.97· delayed

Pre-marketNov 3 '26delayed

Mkt cap$509.7MRevenue$25MQ2 FY26Revenue$8MFY25

Compare

Pre-marketNov 3 '26delayed

AGIOAgios Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.

29.93pre 29.90delayed

Price

84.97pre 84.97delayed

$1.8B

Mkt cap

$509.7M

Q2 FY26$45M

Revenue

$25MQ2 FY26

FY25$54M

Revenue

$8MFY25

AGIO29.93vsCRNX84.97Pre-marketNov 3 '26delayed